tradingkey.logo

Braskem SA

BAK
3.550USD
-0.150-4.05%
Close 01/30, 16:00ETQuotes delayed by 15 min
612.48MMarket Cap
LossP/E TTM

Braskem SA

3.550
-0.150-4.05%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Braskem SA

Currency: USD Updated: 2026-01-30

Key Insights

Braskem SA's fundamentals are relatively stable, and its growth potential is good.Its valuation is considered fairly valued, ranking 48 out of 69 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 3.70.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Braskem SA's Score

Industry at a Glance

Industry Ranking
48 / 69
Overall Ranking
242 / 4536
Industry
Chemicals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Braskem SA Highlights

StrengthsRisks
Braskem SA is a Brazil-based integrated petrochemical company for the first and second generation of thermoplastic resins. The Company's activities are divided into three operational segments: Brazil; the United States and Europe; and Mexico. The Brazil segment is focused on the production of polyethylene (PE), polypropylene (PP) and polyvinylchloride (PVC) resins, in addition to basic chemical inputs such as ethylene, propylene, butadiene, benzene, toluene, chlorine, soda, and solvents, among others. The United States and Europe segment is responsible for the production of polypropylene in units in the United States and Germany. The Mexico segment consists of the operation of ethylene cracker and polyethylene units located in Mexico.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 14.36B.
Undervalued
The company’s latest PB is -2.13, at a low 3-year percentile range.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 13.52K shares of this stock.

Analyst Rating

Based on 5 analysts
Hold
Current Rating
3.700
Target Price
-3.65%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-01-30

The current financial score of Braskem SA is 6.10, ranking 62 out of 69 in the Chemicals industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 3.18B, representing a year-over-year decrease of 17.18%, while its net profit experienced a year-over-year decrease of 95.54%.

Score

Industry at a Glance

Previous score
6.10
Change
0

Financials

5.49

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

10.00

Operational Efficiency

6.57

Growth Potential

3.66

Shareholder Returns

4.78

Braskem SA's Company Valuation

Currency: USD Updated: 2026-01-30

The current valuation score of Braskem SA is 7.88, ranking 33 out of 69 in the Chemicals industry. Its current P/E ratio is -1.50, which is -55.87% below the recent high of -0.66 and -3777.26% above the recent low of -58.03.

Score

Industry at a Glance

Previous score
7.88
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 48/69
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-01-30

The current earnings forecast score of Braskem SA is 6.40, ranking 50 out of 69 in the Chemicals industry. The average price target is 3.75, with a high of 4.50 and a low of 2.80.

Score

Industry at a Glance

Previous score
6.40
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts
Hold
Current Rating
3.700
Target Price
-3.65%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

21
Total
10
Median
12
Average
Company name
Ratings
Analysts
Braskem SA
BAK
5
Sherwin-Williams Co
SHW
28
Linde PLC
LIN
27
PPG Industries Inc
PPG
26
Air Products and Chemicals Inc
APD
25
Dow Inc
DOW
21
1
2
3
4

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-01-30

The current price momentum score of Braskem SA is 8.69, ranking 34 out of 69 in the Chemicals industry. Currently, the stock price is trading between the resistance level at 4.07 and the support level at 2.92, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.90
Change
-0.21

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.082
Buy
RSI(14)
59.929
Neutral
STOCH(KDJ)(9,3,3)
65.732
Sell
ATR(14)
0.219
High Vlolatility
CCI(14)
43.053
Neutral
Williams %R
43.709
Buy
TRIX(12,20)
0.978
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
3.706
Sell
MA10
3.495
Buy
MA20
3.274
Buy
MA50
3.061
Buy
MA100
2.906
Buy
MA200
3.185
Buy

Institutional Confidence

Currency: USD Updated: 2026-01-30

The current institutional shareholding score of Braskem SA is 3.00, ranking 52 out of 69 in the Chemicals industry. The latest institutional shareholding proportion is 6.16%, representing a quarter-over-quarter decrease of 2.61%. The largest institutional shareholder is The Vanguard, holding a total of 560.47K shares, representing 0.32% of shares outstanding, with 0.00% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
560.47K
--
Morgan Stanley Investment Management Inc. (US)
313.39K
-32.63%
State Street Investment Management (US)
290.70K
+6.69%
Aperio Group, LLC
238.23K
+34.51%
Goldman Sachs & Company, Inc.
203.30K
+21.80%
UBS Financial Services, Inc.
760.78K
+6.44%
Point72 Asset Management, L.P.
Star Investors
138.36K
-55.40%
American Century Investment Management, Inc.
112.73K
+0.36%
X-Square Capital, LLC
85.00K
--
1
2

Risk Assessment

Currency: USD Updated: 2026-01-30

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Chemicals domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Braskem SA is 3.95, ranking 51 out of 69 in the Chemicals industry. The company's beta value is 1.88. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.95
Change
0
Beta vs S&P 500 index
1.88
VaR
+5.25%
240-Day Maximum Drawdown
+48.60%
240-Day Volatility
+58.58%

Return

Best Daily Return
60 days
+20.40%
120 days
+20.40%
5 years
+20.82%
Worst Daily Return
60 days
-7.36%
120 days
-14.71%
5 years
-14.71%
Sharpe Ratio
60 days
+2.55
120 days
+0.83
5 years
-0.27

Risk Assessment

Maximum Drawdown
240 days
+48.60%
3 years
+81.02%
5 years
+91.08%
Return-to-Drawdown Ratio
240 days
-0.37
3 years
-0.20
5 years
-0.18
Skewness
240 days
+0.71
3 years
+0.99
5 years
+0.80

Volatility

Realised Volatility
240 days
+58.58%
5 years
+55.52%
Standardised True Range
240 days
+4.53%
5 years
+12.26%
Downside Risk-Adjusted Return
120 days
+144.08%
240 days
+144.08%
Maximum Daily Upside Volatility
60 days
+68.58%
Maximum Daily Downside Volatility
60 days
+49.51%

Liquidity

Average Turnover Rate
60 days
+0.12%
120 days
+0.12%
5 years
--
Turnover Deviation
20 days
+9.52%
60 days
+10.46%
120 days
+7.49%

Peer Comparison

Chemicals
Braskem SA
Braskem SA
BAK
6.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CF Industries Holdings Inc
CF Industries Holdings Inc
CF
8.82 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Linde PLC
Linde PLC
LIN
8.55 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Air Products and Chemicals Inc
Air Products and Chemicals Inc
APD
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Koppers Holdings Inc
Koppers Holdings Inc
KOP
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stepan Co
Stepan Co
SCL
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI